Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Stockholders' Equity, Beginning Balance, Amount at Dec. 31, 2022	$ 89,902	$ 28	$ 636,001	$ (95)	$ (546,032)
Stockholders' Equity, Beginning Balance, Shares at Dec. 31, 2022		28,268,389
Shares issued for the exercise of stock options and vesting of restricted stock units, Amount	761		761
Shares issued for the exercise of stock options and vesting of restricted stock units, Shares		243,598
Shares redeemed for employee tax withholdings, Amount	(337)		(337)
Shares redeemed for employee tax withholdings, Shares		(24,631)
Stock-based compensation expense	3,295		3,295
Issuance of common stock for public offering, net of underwriting discounts, commissions and offering costs, Amount	53,600	$ 5	53,595
Issuance of common stock for public offering, net of underwriting discounts, commissions and offering costs, Shares		4,600,000
Issuance of common stock for at-the-market offerings, net of issuance costs, Amount	10,914	$ 1	10,913
Issuance of common stock for at-the-market offerings, net of issuance costs, Shares		$ 879,341
Unrealized loss on short-term investments and cash equivalents, net of tax	84			84
Foreign currency translation adjustment	2			2
Net Income (Loss)	(13,212)				(13,212)
Stockholders' Equity, Ending Balance, Amount at Mar. 31, 2023	145,009	$ 34	704,228	(9)	(559,244)
Stockholders' Equity, Ending Balance, Shares at Mar. 31, 2023		33,966,697
Stockholders' Equity, Beginning Balance, Amount at Dec. 31, 2022	89,902	$ 28	636,001	(95)	(546,032)
Stockholders' Equity, Beginning Balance, Shares at Dec. 31, 2022		28,268,389
Unrealized loss on short-term investments and cash equivalents, net of tax	38
Net Income (Loss)	(39,431)
Stockholders' Equity, Ending Balance, Amount at Sep. 30, 2023	161,479	$ 36	746,966	(60)	(585,463)
Stockholders' Equity, Ending Balance, Shares at Sep. 30, 2023		35,847,685
Stockholders' Equity, Beginning Balance, Amount at Mar. 31, 2023	145,009	$ 34	704,228	(9)	(559,244)
Stockholders' Equity, Beginning Balance, Shares at Mar. 31, 2023		33,966,697
Shares issued for the exercise of stock options and vesting of restricted stock units, Amount	2,599		2,599
Shares issued for the exercise of stock options and vesting of restricted stock units, Shares		316,092
Stock-based compensation expense	3,955		3,955
Shares issued for the employee stock purchase plan, Amount	536		536
Shares issued for the employee stock purchase plan, Shares		50,504
Issuance of common stock for public offering, net of underwriting discounts, commissions and offering costs, Shares		834,748
Issuance of common stock for at-the-market offerings, net of issuance costs, Amount	18,957	$ 1	18,956
Unrealized loss on short-term investments and cash equivalents, net of tax	(65)			(65)
Foreign currency translation adjustment	1			1
Net Income (Loss)	(13,804)				(13,804)
Stockholders' Equity, Ending Balance, Amount at Jun. 30, 2023	157,188	$ 35	730,274	(73)	(573,048)
Stockholders' Equity, Ending Balance, Shares at Jun. 30, 2023		35,168,041
Shares issued for the exercise of stock options and vesting of restricted stock units, Amount	1,994		1,994
Shares issued for the exercise of stock options and vesting of restricted stock units, Shares		289,010
Shares redeemed for employee tax withholdings, Amount	(1,084)		(1,084)
Shares redeemed for employee tax withholdings, Shares		(37,366)
Stock-based compensation expense	4,071		4,071
Issuance of common stock for at-the-market offerings, net of issuance costs, Amount	11,712	$ 1	11,711
Issuance of common stock for at-the-market offerings, net of issuance costs, Shares		$ 428,000
Unrealized loss on short-term investments and cash equivalents, net of tax	19			19
Foreign currency translation adjustment	(6)			(6)
Net Income (Loss)	(12,415)				(12,415)
Stockholders' Equity, Ending Balance, Amount at Sep. 30, 2023	161,479	$ 36	746,966	(60)	(585,463)
Stockholders' Equity, Ending Balance, Shares at Sep. 30, 2023		35,847,685
Stockholders' Equity, Beginning Balance, Amount at Dec. 31, 2023	$ 160,362	$ 36	754,971	(5)	(594,640)
Stockholders' Equity, Beginning Balance, Shares at Dec. 31, 2023	36,139,513	36,139,513
Shares issued for the exercise of stock options and vesting of restricted stock units, Amount	$ 10,153	$ 1	10,152
Shares issued for the exercise of stock options and vesting of restricted stock units, Shares		1,061,336
Shares redeemed for employee tax withholdings, Amount	(2,134)		(2,134)
Shares redeemed for employee tax withholdings, Shares		(39,096)
Stock-based compensation expense	4,696		4,696
Unrealized loss on short-term investments and cash equivalents, net of tax	(45)			(45)
Foreign currency translation adjustment	(3)			(3)
Net Income (Loss)	(9,100)				(9,100)
Stockholders' Equity, Ending Balance, Amount at Mar. 31, 2024	163,929	$ 37	767,685	(53)	(603,740)
Stockholders' Equity, Ending Balance, Shares at Mar. 31, 2024		37,161,753
Stockholders' Equity, Beginning Balance, Amount at Dec. 31, 2023	$ 160,362	$ 36	754,971	(5)	(594,640)
Stockholders' Equity, Beginning Balance, Shares at Dec. 31, 2023	36,139,513	36,139,513
Exercise of stock options, shares	1,809,836
Unrealized loss on short-term investments and cash equivalents, net of tax	$ 524
Net Income (Loss)	(21,517)
Stockholders' Equity, Ending Balance, Amount at Sep. 30, 2024	$ 277,261	$ 40	892,857	521	(616,157)
Stockholders' Equity, Ending Balance, Shares at Sep. 30, 2024	40,254,105	40,254,105
Stockholders' Equity, Beginning Balance, Amount at Mar. 31, 2024	$ 163,929	$ 37	767,685	(53)	(603,740)
Stockholders' Equity, Beginning Balance, Shares at Mar. 31, 2024		37,161,753
Shares issued for the exercise of stock options and vesting of restricted stock units, Amount	3,103	$ 1	3,102
Shares issued for the exercise of stock options and vesting of restricted stock units, Shares		363,105
Stock-based compensation expense	6,105		6,105
Shares issued for the employee stock purchase plan, Amount	737		737
Shares issued for the employee stock purchase plan, Shares		38,905
Issuance of common stock for public offering, net of underwriting discounts, commissions and offering costs, Amount	107,477	$ 2	107,475
Issuance of common stock for public offering, net of underwriting discounts, commissions and offering costs, Shares		2,053,571
Unrealized loss on short-term investments and cash equivalents, net of tax	(64)			(64)
Foreign currency translation adjustment	(1)			(1)
Net Income (Loss)	(6,079)				(6,079)
Stockholders' Equity, Ending Balance, Amount at Jun. 30, 2024	275,207	$ 40	885,104	(118)	(609,819)
Stockholders' Equity, Ending Balance, Shares at Jun. 30, 2024		39,617,334
Shares issued for the exercise of stock options and vesting of restricted stock units, Amount	3,835		3,835
Shares issued for the exercise of stock options and vesting of restricted stock units, Shares		683,489
Shares redeemed for employee tax withholdings, Amount	(2,634)		(2,634)
Shares redeemed for employee tax withholdings, Shares		(46,718)
Stock-based compensation expense	6,552		6,552
Unrealized loss on short-term investments and cash equivalents, net of tax	633			633
Foreign currency translation adjustment	6			6
Net Income (Loss)	(6,338)				(6,338)
Stockholders' Equity, Ending Balance, Amount at Sep. 30, 2024	$ 277,261	$ 40	$ 892,857	$ 521	$ (616,157)
Stockholders' Equity, Ending Balance, Shares at Sep. 30, 2024	40,254,105	40,254,105